ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.768,96
0,33%
S&P 500
5.308,13
0,09%
Dow Jones
39.806,77
-0,49%
Euro vs US Dollar
1,08595
-0,14%
Bitcoin
71.427,01
7,76%
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. USOTC
  6. Therapeutic Solutions International Inc (PK) (TSOI)

  7. Therapeutic Solutions International Inc (PK) (TSOI) News

TSOI

Therapeutic Solutions (PK) (TSOI)

Therapeutic Solutions International Inc (PK)
Von:
Sortieren nach:
 Showing the most relevant articles for your search:USOTC:TSOI
DatumZeitQuelleÜberschriftSymbolFirma
15/05/202418h01Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBUSOTC:TSOITherapeutic Solutions International Inc (PK)
06/05/202412h03Edgar (US Regulatory)Form 8-K - Current reportUSOTC:TSOITherapeutic Solutions International Inc (PK)
26/02/202420h15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:TSOITherapeutic Solutions International Inc (PK)
26/02/202420h12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:TSOITherapeutic Solutions International Inc (PK)
21/02/202423h25Edgar (US Regulatory)Form 8-K - Current reportUSOTC:TSOITherapeutic Solutions International Inc (PK)
20/02/202412h16Edgar (US Regulatory)Form 8-K - Current reportUSOTC:TSOITherapeutic Solutions International Inc (PK)
08/02/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessUSOTC:TSOITherapeutic Solutions International Inc (PK)
06/02/202412h34Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]USOTC:TSOITherapeutic Solutions International Inc (PK)
22/01/202421h42Edgar (US Regulatory)Form 8-K - Current reportUSOTC:TSOITherapeutic Solutions International Inc (PK)
18/01/202400h15Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933USOTC:TSOITherapeutic Solutions International Inc (PK)
04/01/202422h03Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementUSOTC:TSOITherapeutic Solutions International Inc (PK)
22/12/202320h44Edgar (US Regulatory)Form 8-K - Current reportUSOTC:TSOITherapeutic Solutions International Inc (PK)
14/11/202318h39Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:TSOITherapeutic Solutions International Inc (PK)
17/10/202301h17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:TSOITherapeutic Solutions International Inc (PK)
17/10/202301h13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:TSOITherapeutic Solutions International Inc (PK)
13/10/202320h50Edgar (US Regulatory)Form 8-K - Current reportUSOTC:TSOITherapeutic Solutions International Inc (PK)
13/09/202319h44Edgar (US Regulatory)Form 8-K - Current reportUSOTC:TSOITherapeutic Solutions International Inc (PK)
21/08/202323h24Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:TSOITherapeutic Solutions International Inc (PK)
21/08/202323h24Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:TSOITherapeutic Solutions International Inc (PK)
15/08/202313h10Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBUSOTC:TSOITherapeutic Solutions International Inc (PK)
07/07/202322h29Edgar (US Regulatory)Form 8-K - Current reportUSOTC:TSOITherapeutic Solutions International Inc (PK)
29/03/202322h10Edgar (US Regulatory)Annual Report (10-k)USOTC:TSOITherapeutic Solutions International Inc (PK)
27/03/202312h02Edgar (US Regulatory)Current Report Filing (8-k)USOTC:TSOITherapeutic Solutions International Inc (PK)
21/02/202319h59Edgar (US Regulatory)Current Report Filing (8-k)USOTC:TSOITherapeutic Solutions International Inc (PK)
16/02/202312h05Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:TSOITherapeutic Solutions International Inc (PK)
15/02/202319h57Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:TSOITherapeutic Solutions International Inc (PK)
31/01/202312h12Edgar (US Regulatory)Securities Registration Statement (s-1/a)USOTC:TSOITherapeutic Solutions International Inc (PK)
18/01/202316h50Edgar (US Regulatory)Securities Registration Statement (s-1/a)USOTC:TSOITherapeutic Solutions International Inc (PK)
09/01/202323h39Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:TSOITherapeutic Solutions International Inc (PK)
09/01/202323h36Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:TSOITherapeutic Solutions International Inc (PK)
 Showing the most relevant articles for your search:USOTC:TSOI

Kürzlich von Ihnen besucht

NASDAQ
NVDA
NVIDIA
CCOM
US100
US Tech 100
TG
NOV
Novo Nordisk
DBI
DAX
DAX
USOTC
ADDYY
Adidas (QX)
FX
EURGBP
Euro vs Sterling
DBI
SDXP
SDAX
NASDAQ
AAPL
Apple
NYSE
NKE
Nike
FX
EURUSD
Euro vs US Dollar
USOTC
BASFY
BASF (QX)
TG
CBK
Commerzbank
CCOM
SILVER
SILVER
PM
XAUUSD
Gold vs US Dollar
USOTC
RHHBY
Roche (QX)
TG
BAYN
Bayer
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten